TLR4 and atrial fibrillation: TLR4 signaling, which is dampened by AF in utero, is inhibited in the gut of fetal mice (tested on day 18.5 of gestation, term gestation is 19–21 days) treated with lipopolysaccharide (LPS) and AF compared to fetal mice stimulated with LPS and a saline solution.